Moreover, this compound was able to repress the transactivation of CYP19 promoters I.3 and II in SK-BR-3 cells, which indicates that resveratrol could be able to reduce localized estrogen production in breast cancer cells [18]. This evidence concerns the gene CYP19A1 and breast carcinoma.